XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D208. A total of 5 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $434,000 | -39.2% | 724,134 | -3.6% | 0.02% | -7.4% |
| Q3 2016 | $714,000 | -38.5% | 751,289 | -25.0% | 0.03% | -55.7% |
| Q2 2016 | $1,161,000 | +8.2% | 1,001,170 | -3.8% | 0.06% | +13.0% |
| Q1 2016 | $1,073,000 | -35.7% | 1,040,194 | -6.5% | 0.05% | -41.3% |
| Q4 2015 | $1,668,000 | -7.0% | 1,111,962 | -3.3% | 0.09% | +24.3% |
| Q3 2015 | $1,794,000 | -18.8% | 1,149,886 | -0.1% | 0.07% | -8.6% |
| Q2 2015 | $2,210,000 | -26.7% | 1,150,981 | -12.2% | 0.08% | -35.7% |
| Q1 2015 | $3,016,000 | – | 1,311,453 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|